What We're Reading: Page 246
Industry reads hand-picked by our editors
Aug 17, 2018
-
The New York Times
Bleak new estimates in drug epidemic: A record 72,000 overdose deaths in 2017
-
Reuters
China sacks top official over vaccine scandal, firm may de-list
-
Genetic Engineering & Biotechnology News
Can transcriptomics help find the right time to administer chemotherapy?
-
Business Insider
Mylan quietly made an acquisition for almost half a billion dollars in July that it didn't tell investors about right away
Aug 16, 2018
Aug 15, 2018
Aug 14, 2018
Aug 13, 2018
-
The New York Times
Nebraska plans first execution in 21 years. Not so fast, drug company says.
-
The Wall Street Journal
China’s drugs problem spells opportunity for pharma giants
-
Reuters
Roundup cancer verdict sends Bayer shares sliding
Aug 10, 2018
-
Kaiser Health News
Trump administration sinks teeth into paring down drug prices, on 5 key points
-
Bloomberg
Red flags raised at Chinese heart drug maker year before recall
-
BioCentury
FDA rolls out guidance for seamless cancer trials
-
The Washington Post
Death reports make the opioid crisis personal for doctors
Aug 09, 2018
-
The Wall Street Journal
New Marijuana-Based Epilepsy Treatment to Cost $32,500 a Year
-
Bloomberg
The $250 Biohack That's Revolutionizing Life With Diabetes
-
MIT Technology Review
US scientist who edited human embryos with CRISPR responds to critics
Previous
